Compounds > reserpine
Page last updated: 2024-08-17

reserpine and nalidixic acid

reserpine has been researched along with nalidixic acid in 11 studies

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19905 (45.45)18.7374
1990's0 (0.00)18.2507
2000's2 (18.18)29.6817
2010's4 (36.36)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Gibb, JW; Hanson, GR; Ritter, JK; Schmidt, CJ1
Jackson, DM; Ross, SB1
Bagchi, SP1
Bagchi, P; Bagchi, SP; Smith, TM1
Jiminez de Anta, MT; Ribera, A; Ruiz, J; Vila, J1

Reviews

1 review(s) available for reserpine and nalidixic acid

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

10 other study(ies) available for reserpine and nalidixic acid

ArticleYear
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
    Journal of medicinal chemistry, 2008, Nov-13, Volume: 51, Issue:21

    Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship

2008
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
    Bioorganic & medicinal chemistry, 2012, Nov-15, Volume: 20, Issue:22

    Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship

2012
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013
Dopamine-mediated increases in nigral substance P-like immunoreactivity.
    Biochemical pharmacology, 1985, Sep-01, Volume: 34, Issue:17

    Topics: Animals; Citalopram; Clomipramine; Corpus Striatum; Dopamine; Male; Methamphetamine; Nalidixic Acid; Naphthyridines; Nomifensine; Propylamines; Radioimmunoassay; Rats; Rats, Inbred Strains; Reserpine; Serotonin; Substance P; Substantia Nigra

1985
Kinetic properties of the accumulation of 3H-raclopride in the mouse brain in vivo.
    Naunyn-Schmiedeberg's archives of pharmacology, 1989, Volume: 340, Issue:1

    Topics: 4-Butyrolactone; alpha-Methyltyrosine; Amphetamine; Animals; Brain Chemistry; Chromatography, Thin Layer; Male; Methyltyrosines; Mice; Nalidixic Acid; Naphthyridines; Raclopride; Receptors, Dopamine; Reserpine; Salicylamides

1989
Cocaine and phencyclidine. Heterogenous dopaminergic interactions with tetrabenazine.
    Neuropharmacology, 1985, Volume: 24, Issue:1

    Topics: Amphetamine; Animals; Cocaine; Dopamine; Drug Interactions; In Vitro Techniques; Mitochondria; Nalidixic Acid; Naphthyridines; Phencyclidine; Phenylalanine; Rats; Receptors, Dopamine; Reserpine; Synaptosomes; Tetrabenazine; Tyrosine

1985
Drugs in breast milk.
    The Medical letter on drugs and therapeutics, 1974, Mar-15, Volume: 16, Issue:6

    Topics: Anticoagulants; Anticonvulsants; Antineoplastic Agents; Antithyroid Agents; Aspirin; Atropine; Caffeine; Chloramphenicol; Chlorothiazide; Contraceptives, Oral; Ergot Alkaloids; Ethanol; Female; Humans; Hypnotics and Sedatives; Methadone; Milk, Human; Nalidixic Acid; Narcotics; Penicillins; Quinine; Reserpine; Sulfonamides; Tetracycline

1974
Divergent reserpine effects on amfonelic acid and amphetamine stimulation of synaptosomal dopamine formation from phenylalanine.
    Biochemical pharmacology, 1980, Nov-01, Volume: 29, Issue:21

    Topics: Amphetamine; Animals; Brain; Central Nervous System Stimulants; Dopamine; Female; Nalidixic Acid; Naphthyridines; Phenylalanine; Rats; Reserpine; Synaptosomes

1980
Effect of an efflux pump inhibitor on the MIC of nalidixic acid for Acinetobacter baumannii and Stenotrophomonas maltophilia clinical isolates.
    The Journal of antimicrobial chemotherapy, 2002, Volume: 49, Issue:4

    Topics: Acinetobacter; Anti-Infective Agents; Ciprofloxacin; Dipeptides; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Reserpine

2002